5,510 research outputs found
Epigenome-wide association studies for breast cancer risk and risk factors
There have been six epigenome-wide association studies (EWAS) for breast cancer risk using blood DNA from prospective cohorts published thus far, and the only consistent finding is a global loss of methylation observed in breast cancer cases compared with controls, with no individual CpG sites passing validation across studies. In contrast, a more successful approach has been the identification of EWAS signatures of cancer risk factors such as smoking, body mass index, age and alcohol use with numerous validated CpG sites. These signatures may be used as a molecular test to quantify cancer risk associated with these factors. It is clear from the larger EWAS of risk exposures that similar-sized large collaborative studies may be needed to robustly identify DNA methylation signatures of breast cancer risk
Eta Carinae -- Physics of the Inner Ejecta
Eta Carinae's inner ejecta are dominated observationally by the bright
Weigelt blobs and their famously rich spectra of nebular emission and
absorption lines. They are dense (n_e ~ 10^7 to 10^8 cm^-3), warm (T_e ~ 6000
to 7000 K) and slow moving (~40 km/s) condensations of mostly neutral (H^0)
gas. Located within 1000 AU of the central star, they contain heavily
CNO-processed material that was ejected from the star about a century ago.
Outside the blobs, the inner ejecta include absorption-line clouds with similar
conditions, plus emission-line gas that has generally lower densities and a
wider range of speeds (reaching a few hundred km/s) compared to the blobs. The
blobs appear to contain a negligible amount of dust and have a nearly dust-free
view of the central source, but our view across the inner ejecta is severely
affected by uncertain amounts of dust having a patchy distribution in the
foreground. Emission lines from the inner ejecta are powered by photoionization
and fluorescent processes. The variable nature of this emission, occurring in a
5.54 yr event cycle, requires specific changes to the incident flux that hold
important clues to the nature of the central object.Comment: This is Chapter 5 in a book entitled: Eta Carinae and the Supernova
Impostors, Kris Davidson and Roberta M. Humphreys, editors Springe
The Role of the Mucus Barrier in Digestion
Mucus forms a protective layer across a variety of epithelial surfaces. In the gastrointestinal (GI) tract, the barrier has to permit the uptake of nutrients, while excluding potential hazards, such as pathogenic bacteria. In this short review article, we look at recent literature on the structure, location, and properties of the mammalian intestinal secreted mucins and the mucus layer they form over a wide range of length scales. In particular, we look at the structure of the gel-forming glycoprotein MUC2, the primary intestinal secreted mucin, and the influence this has on the properties of the mucus layer. We show that, even at the level of the protein backbone, MUC2 is highly heterogeneous and that this is reflected in the networks it forms. It is evident that a combination of charge and pore size determines what can diffuse through the layer to the underlying gut epithelium. This information is important for the targeted delivery of bioactive molecules, including nutrients and pharmaceuticals, and for understanding how GI health is maintained
Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: a pilot study
Background and Objective: PSEN1-H163Y carriers, at the presymptomatic
stage, have reduced 18FDG-PET binding in the cerebrum of the brain (Scholl
et al., Neurobiol Aging 32:1388–1399, 2011). This could imply dysfunctional
energy metabolism in the brain. In this study, plasma of presymptomatic
PSEN1 mutation carriers was analyzed to understand associated metabolic
changes. Methods: We analyzed plasma from noncarriers (NC, n = 8) and
presymptomatic PSEN1-H163Y mutation carriers (MC, n = 6) via untargeted
metabolomics using gas and liquid chromatography coupled with mass spectrometry, which identified 1199 metabolites. All the metabolites were compared
between MC and NC using univariate analysis, as well as correlated with the
ratio of Ab1–42/Ab1–40, using Spearman’s correlation. Altered metabolites were
subjected to Ingenuity Pathway Analysis (IPA). Results: Based on principal
component analysis the plasma metabolite profiles were divided into dataset A
and dataset B. In dataset A, when comparing between presymptomatic MC and
NC, the levels of 79 different metabolites were altered. Out of 79, only 14 were
annotated metabolites. In dataset B, 37 metabolites were significantly altered
between presymptomatic MC and NC and nine metabolites were annotated. In
both datasets, annotated metabolites represent amino acids, fatty acyls, bile
acids, hexoses, purine nucleosides, carboxylic acids, and glycerophosphatidylcholine species. 1-docosapentaenoyl-GPC was positively correlated, uric acid
and glucose were negatively correlated with the ratio of plasma Ab1–42/Ab1–40
(P < 0.05). Interpretation: This study finds dysregulated metabolite classes,
which are changed before the disease symptom onset. Also, it provides an
opportunity to compare with sporadic Alzheimer’s Disease. Observed findings
in this study need to be validated in a larger and independent Familial Alzheimer’s Disease (FAD) cohort
Monodromy--like Relations for Finite Loop Amplitudes
We investigate the existence of relations for finite one-loop amplitudes in
Yang-Mills theory. Using a diagrammatic formalism and a remarkable connection
between tree and loop level, we deduce sequences of amplitude relations for any
number of external legs.Comment: 24 pages, 6 figures, v2 typos corrected, reference adde
Coherent quantum state storage and transfer between two phase qubits via a resonant cavity
A network of quantum-mechanical systems showing long lived phase coherence of
its quantum states could be used for processing quantum information. As with
classical information processing, a quantum processor requires information bits
(qubits) that can be independently addressed and read out, long-term memory
elements to store arbitrary quantum states, and the ability to transfer quantum
information through a coherent communication bus accessible to a large number
of qubits. Superconducting qubits made with scalable microfabrication
techniques are a promising candidate for the realization of a large scale
quantum information processor. Although these systems have successfully passed
tests of coherent coupling for up to four qubits, communication of individual
quantum states between qubits via a quantum bus has not yet been demonstrated.
Here, we perform an experiment demonstrating the ability to coherently transfer
quantum states between two superconducting Josephson phase qubits through a
rudimentary quantum bus formed by a single, on chip, superconducting
transmission line resonant cavity of length 7 mm. After preparing an initial
quantum state with the first qubit, this quantum information is transferred and
stored as a nonclassical photon state of the resonant cavity, then retrieved at
a later time by the second qubit connected to the opposite end of the cavity.
Beyond simple communication, these results suggest that a high quality factor
superconducting cavity could also function as a long term memory element. The
basic architecture presented here is scalable, offering the possibility for the
coherent communication between a large number of superconducting qubits.Comment: 17 pages, 4 figures (to appear in Nature
Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours
<p>Abstract</p> <p>Background</p> <p><it>ASCL1 </it>role in pancreatic endocrine tumourigenesis has not been established. Recently it was suggested that ASCL1 negatively controls expression of the Wnt signalling antagonist <it>DKK1</it>. Notch signalling regulates expression of TPH1, the rate limiting enzyme in the biosyntesis of serotonin. Understanding the development and proliferation of pancreatic endocrine tumours (PETs) is essential for the development of new therapies.</p> <p>Methods</p> <p><it>ASCL1 </it>target genes in the pancreatic endocrine tumour cell line BON1 were identified by RNA interference and microarray expression analysis. Protein expressions of selected target genes in PETs were evaluated by immunohistochemistry.</p> <p>Results</p> <p>158 annotated <it>ASCL1 </it>target genes were identified in BON1 cells, among them DKK1 and TPH1 that were negatively regulated by ASCL1. An inverse relation of ASCL1 to DKK1 protein expression was observed for 15 out of 22 tumours (68%). Nine tumours displayed low ASCL1/high DKK1 and six tumours high ASCL1/low DKK1 expression. Remaining PETs showed high ASCL1/high DKK1 (n = 4) or low ASCL1/low DKK1 (n = 3) expression. Nine of twelve analysed PETs (75%) showed TPH1 expression with no relation to ASCL1.</p> <p>Conclusion</p> <p>A number of genes with potential importance for PET tumourigenesis have been identified. <it>ASCL1 </it>negatively regulated the Wnt signalling antagonist <it>DKK1</it>, and <it>TPH1 </it>expression in BON1 cells. In concordance with these findings DKK1 showed an inverse relation to ASCL1 expression in a subset of PETs, which may affect growth control by the Wnt signalling pathway.</p
Genetic Predisposition to Mosaic Chromosomal Loss Is Associated With Functional Outcome After Ischemic Stroke.
Background and Objectives: To test the hypothesis that a predisposition to acquired genetic alterations is associated with ischemic stroke outcome by investigating the association between a polygenic risk score (PRS) for mosaic loss of chromosome Y (mLOY) and outcome in a large international data set. Methods: We used data from the genome-wide association study performed within the Genetics of Ischemic Stroke Functional Outcome network, which included 6,165 patients (3,497 men and 2,668 women) with acute ischemic stroke of mainly European ancestry. We assessed a weighted PRS for mLOY and examined possible associations with the modified Rankin Scale (mRS) score 3 months poststroke in logistic regression models. We investigated the whole study sample as well as men and women separately. Results: Increasing PRS for mLOY was associated with poor functional outcome (mRS score >2) with an odds ratio (OR) of 1.11 (95% confidence interval [CI] 1.03-1.19) per 1 SD increase in the PRS after adjustment for age, sex, ancestry, stroke severity (NIH Stroke Scale), smoking, and diabetes mellitus. In sex-stratified analyses, we found a statistically significant association in women (adjusted OR 1.20, 95% CI 1.08-1.33). In men, the association was in the same direction (adjusted OR 1.04, 95% CI 0.95-1.14), and we observed no significant genotype-sex interaction. Discussion: In this exploratory study, we found associations between genetic variants predisposing to mLOY and stroke outcome. The significant association in women suggests underlying mechanisms related to genomic instability that operate in both sexes. These findings need replication and mechanistic exploration
Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease
We have recently reported that a polymorphism in the cell division cycle (CDC2) gene, designated Ex6 + 7I/D, is associated with Alzheimer's disease (AD). The CDC2 gene is located on chromosome 10q21.1 close to the marker D10S1225 linked to AD. Active cdc2 accumulates in neurons containing neurofibrillary tangles (NFT), a process that can precede the formation of NFT. Therefore, CDC2 is a promising candidate susceptibility gene for AD. We investigated the possible effects of the CDC2 polymorphism on cerebrospinal fluid (CSF) biomarkers in AD patients. CDC2 genotypes were evaluated in relation to CSF protein levels of total tau, phospho-tau and beta-amyloid (1-42) in AD patients and control individuals, and in relation to the amount of senile plaques and NFT in the frontal cortex and in the hippocampus in patients with autopsy-proven AD and controls. The CDC2 Ex6 + 7I allele was associated with a gene dose-dependent increase of CSF total tau levels (F-2,F- 626 = 7.0, p = 0.001) and the homozygous CDC2Ex6 +7II genotype was significantly more frequent among AD patients compared to controls (p = 0.006, OR = 1.57, 95% CI 1.13-2.17). Our results provide further evidence for an involvement of cdc2 in the pathogenesis of AD. Copyright (C) 2005 S. Karger AG, Basel
Dietary elimination of children with food protein induced gastrointestinal allergy – micronutrient adequacy with and without a hypoallergenic formula?
Background:
The cornerstone for management of Food protein-induced gastrointestinal allergy (FPGIA) is dietary exclusion; however the micronutrient intake of this population has been poorly studied. We set out to determine the dietary intake of children on an elimination diet for this food allergy and hypothesised that the type of elimination diet and the presence of a hypoallergenic formula (HF) significantly impacts on micronutrient intake.
Method:
A prospective observational study was conducted on children diagnosed with FPIGA on an exclusion diet who completed a 3 day semi-quantitative food diary 4 weeks after commencing the diet. Nutritional intake where HF was used was compared to those without HF, with or without a vitamin and mineral supplement (VMS).
Results:
One-hundred-and-five food diaries were included in the data analysis: 70 boys (66.7%) with median age of 21.8 months [IQR: 10 - 67.7]. Fifty-three children (50.5%) consumed a HF and the volume of consumption was correlated to micronutrient intake. Significantly (p <0.05) more children reached their micronutrient requirements if a HF was consumed. In those without a HF, some continued not to achieve requirements in particular for vitamin D and zinc, in spite of VMS.
Conclusion:
This study points towards the important micronutrient contribution of a HF in children with FPIGA. Children, who are not on a HF and without a VMS, are at increased risk of low intakes in particular vitamin D and zinc. Further studies need to be performed, to assess whether dietary intake translates into actual biological deficiencies
- …